“Both companies are synonymous with delivering proven outcomes and ROI for health systems,” said Mohan Giridharadas, LeanTaaS Founder and CEO. “Together, we’ll make it easier for health systems to know what’s coming and get more out of their existing assets by unlocking capacity, generating new sources of revenue, streamlining resource allocation and deployment, increasing throughput, and decreasing delays in all major areas of a hospital. We are excited to collaborate with the Siemens Healthineers team to create long-lasting, meaningful change for health systems at such a critical time in the industry.”
The outcomes described herein are based on results that were achieved in a customer's unique setting. Because there is no “typical” hospital and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption), there can be no guarantee that other customers will achieve the same results.
Ad Statistics
Times Displayed: 50459
Times Visited: 1437 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About LeanTaaS
LeanTaaS provides software solutions that combine lean principles, predictive and prescriptive analytics, and machine learning to transform hospital and infusion center operations. The company’s software is being used by over 175 health systems across the nation, which rely on the iQueue cloud-based solutions to increase patient access, decrease wait times, reduce healthcare delivery costs, and improve revenue. LeanTaaS is headquartered in Santa Clara, CA with offices in Newton, MA and Charlotte, NC.
About Siemens Healthineers
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.
Back to HCB News
